Early Detection Saves Lives
Easy to use tests that detect pre-cancer and cancer early are critical to patient survival.
Creating Simple Tests for Early Detection of Disease
Cancer is a Big, Bad Global Disease
Colon Cancer is the 2nd leading cause of cancer deaths.
1.3 Million Diagnosed
700 Thousand Deaths*
ColoPlex™ is an accurate early detection blood test which can drive the right people to confirmatory colonoscopy and aims to improve patient outcomes.
EDP Biotech Corporation
We are committed to developing simple, accurate and cost-effective diagnostics that detect disease early.
EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of immunodiagnostic tests.
EDP performs research and develops products to identify and purify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection.